The regulatory mechanisms of such coordination remain unclear, although both attractive and repulsive axon guidance molecules may be involved in the signaling pathway. Here we show that expression of a neural secreted chemorepellent semaphorin 3A (Sema3A) is remarkably upregulated in satellite cells of resident myogenic stem cells that are positioned beneath the basal lamina of mature muscle fibers, when treated with hepatocyte growth factor (HGF), established as an essential cue in muscle fiber growth and regeneration. When satellite cells were treated with HGF in primary cultures of cells or muscle fibers, Sema3A message and protein were upregulated as revealed by reverse transcriptionpolymerase chain reaction and immunochemical studies. Other growth factors had no inductive effect except for a slight effect of epidermal growth factor treatment. Sema3A upregulation was HGF dose dependent with a maximum (about 7-to 8-fold units relative to the control) at 10 -25 ng/ml and occurred exclusively at the earlydifferentiation stage, as characterized by the level of myogenin expression and proliferation (bromodeoxyuridine incorporation) of the cells. Neutralizing antibody to the HGF-specific receptor, c-met, did not abolish the HGF response, indicating that c-met may not mediate the Sema3A expression signaling. Finally, in vivo Sema3A was upregulated in the differentiation phase of satellite cells isolated from muscle regenerating following crush injury. Overall, the data highlight a heretofore unexplored and active role for satellite cells as a key source of Sema3A expression triggered by HGF, hence suggesting that regenerative activity toward motor innervation may importantly reside in satellite cells and could be a crucial contributor during postnatal myogenesis.
induced hypertrophy. Successful regeneration of functional muscle requires restoration of the vascular and neural networks in spatiotemporal coordination with myogenesis driven by hepatocyte growth factor and the nitric oxide free radical. This includes sequential events of satellite cells, resident myogenic stem cells, including activation, proliferation, differentiation and fusion with existing muscle fibers (reviewed in Refs. 12, 27, 55, 74, and 81) . Coordination of intramuscular motor innervation during regeneration of muscle may be associated with the plasticity or remodeling potential of neuromuscular connections formed between motor nerve terminals and a circumscribed postsynaptic region on each muscle fiber. This complex interdependence is expressed as a wide range of trophic interactions which generally depend on the distribution, density, patterning, and sprouting of motor neuron terminals. The complexity becomes particularly apparent when nervemuscle contact and communication are interrupted by trophic abnormalities, as seen in neuromuscular diseases such as amyotrophic lateral sclerosis and murine motor end-plate disease (see reviews of Refs. 24 and 75 for more details). However, the regulatory mechanisms that determine configuration of the neuron network and the synaptic contact remain unclear, because both attractive and repulsive cues for axon guidance may be involved in the regeneration mechanisms.
The past decade has seen remarkable progress in identifying the molecules involved in axonal guidance. Several families of axon-guidance cue ligands and their receptors are now identified, including semaphorins with neuropilins and plexins, ephrins and Eph receptors, netrins with UNC5 and DCC, and slits with Robos (25, 43, 72 ; reviewed in Ref. 21 ). In the mature brain, these axon-guidance factors may function to maintain established connections and modulate morphological changes in existing dendritic branches and spines or in synapse formation and stabilization. The expression of several axonguidance molecules and their receptors, both attractive and repulsive, is upregulated upon nervous system injury, and this may relate to the ability of injured neurons to regenerate and possibly to neuronal cell death (9, 26, 37, 47, 48, 54, 59) .
Semaphorin 3A (Sema3A, also referred to as SemaIII, SemD, and collapsin), a class 3 vertebrate-secreted semaphorin (56) and a potent neural chemorepellent for sensory, sympathetic, and motor axons (32, 34, 42, 52, 63, 73) , is the best characterized among a large semaphorin family (reviewed in Refs. 21 and 49) . Sema3A causes growth-cone collapse and retraction and repels sensory and sympathetic axons in cultures (13, 36, 39) , and targeted inactivation of the Sema3A gene is near-lethal within the first postnatal week due to the disruption of neural patterning and projections. These findings indicate the importance of Sema3A signaling for directional guidance of nerve fibers in several developing organs including nerves, bones, and heart (10, 28, 64) . Additionally, emerging evidence shows that Sema3A may be involved in structural plasticity in response to lesions in the nervous system, since Sema3A continues to be expressed in adult tissues. It may be involved in nerve adjustments connected with plasticity and injuryinduced events, although possibly at lower levels and with a more restricted distribution than during prenatal development (23, 44, 50) . This view is supported by the recent observation that a selective Sema3A inhibitor, SM-216289, can enhance regenerative responses and functional recovery of injured spinal cord in adult rats (31) . These observations indicate that Sema3A may play a critical role in regenerative motor-innervation activity and that its up-and subsequent downregulation must be controlled by precise mechanisms (20) .
In an effort to understand how Sema3A expression is regulated in regenerating adult skeletal muscle tissue, experiments in the present study were designed to test the hypothesis that satellite cells are involved in regulating Sema3A expression. Satellite cells are positioned beneath the basal lamina of mature skeletal muscle fibers, and several studies have noted an accumulation of satellite cells at the myoneural junction with about 20-fold greater frequency than at nonjunctional regions in adult rat and human muscles (33, 76 ; reviewed in Ref. 12 ). Hence, the satellite cell population is considered to be a plausible source of Sema3A production and therefore as a communication partner with the respective motoneuron branches to muscle fibers, even though Sema3A mRNA expression was observed in terminal Schwann cells in models of denervation or paralysis (20) . This novel idea would extend the well-characterized role of satellite cells in initiating postnatal myogenesis and repair to their participation in reinnervating myofibers.
Activated satellite cells respond to several growth factors in their environment, and they express many of those same growth factors. Among these growth factors is hepatocyte growth factor (HGF); HGF is released from its extracellular tethering to activate quiescent satellite cells in response to muscle injury or mechanical stretch (65) (66) (67) 69 ; reviewed in Refs. 7, 8, 70, and 81) . Additionally, HGF is known to be produced in satellite cells and liver and spleen cells in response to muscle injury (58, 61) , and is present along with other growth factors including fibroblast growth factor 2, platelet-derived growth factor-BB (PDGF-BB), and transferrin in the saline extract of lightly crushed muscle tissue that is used to model diffusible factors derived from experimental muscle injury that may function in muscle regeneration (6, 11, 15, 16, 65) .
As a first step toward studying the possibility that satellite cells may promote intramuscular neuritogenesis by motor neurons, we examined whether satellite cells can produce Sema3A in response to growth factors that have been identified in muscle tissue. Results clearly demonstrate that Sema3A expression is significantly upregulated in differentiating satellite cells in response to HGF in vitro in tissue culture and after muscle crush injury in vivo.
MATERIALS AND METHODS
Materials. Dulbecco's modified Eagle's medium (DMEM, low glucose type, 31600-034), normal horse serum (HS, 16050-122), antibiotic-antimycotic (15240-062), and gentamicin (15710-064) were purchased from Invitrogen (Grand Island, NY). Poly-L-lysine (P9155), bovine plasma fibronectin (F1141), protease type XIV (P5147), and 5-bromo-2Ј-deoxyuridine (BrdU, B5002) were obtained from Sigma (St. Louis, MO).
Recombinant mouse HGF (2207-HG) was purchased from R&D Systems (Minneapolis, MN). Recombinant R 3 -insulin-like growth factor I (R 3 -IGF-I, a potent analog of human IGF-I comprising the complete amino acid sequence with the substitution of Arg for the Glu at position 3; I1146), and human transferrin (T8158) were obtained from Sigma. Recombinant rat epidermal growth factor (EGF; 400-25), recombinant human transforming growth factor-␤2 (TGF-␤2; 100-35), and recombinant human PDGF-BB (100-14B) were purchased from PeproTech EC (London, UK).ported previously (81) . For the immunofluorescence staining on sections of muscle, Alexa Fluor 488-labeled goat anti-rabbit IgG (A11008) from Invitrogen, bovine serum albumin (BSA, A2153) from SigmaAldrich, and Vectashield (H-1000) from Cedarlane Laboratories (Burlington, ON, Canada) were additionally used.
Satellite cell isolation and primary culture. Satellite cells were isolated from muscle groups from the hindlimb and back of 9-mo-old (adult) male Sprague-Dawley rats according to Allen et al. (3) . Briefly, muscle groups from the upper hindlimb and back were excised, trimmed of fat and connective tissue, hand minced with scissors, and digested for 1 h at 37°C with 1.25 mg/ml protease type XIV. Cells were separated from muscle fiber fragments and tissue debris by differential centrifugation and plated on poly-L-lysine and fibronectin-coated dishes in DMEM containing 10% HS, 1% antibiotic-antimycotic mixture, and 0.5% gentamicin (DMEM-10% HS, pH 7.2). Cultures were maintained in a humidified atmosphere of 5% CO 2 at 37°C. In addition, companion satellite cell cultures were immunostained for the presence of desmin at 30 h after plating using a D3 monoclonal anti-desmin antibody, biotinylated anti-mouse IgG antibody, and HRPO-labeled avidin to determine the percentage of myogenic cells present. Cultures with Ͻ95% DAB-positive cells were not used for experiments. In experiments in which conditioned medium was assayed for the presence of Sema3A protein secreted, cultures were washed with serum-free DMEM at 66-h postplating, and treatments were imposed for the next 6 h in the DMEM; conditioned media were collected, centrifuged for 4 min at 1,300 g, and stored at Ϫ80°C until use.
Reverse transcription-polymerase chain reaction. Total RNA was isolated from cultured satellite cells using RNeasy Micro kit according to the manufacturer's recommendation. cDNA was synthesized from 1.8 g of total RNA by a reverse-transcriptase SuperScript III using oligo(dT) primer. Semiquantitative PCR was performed using rTaq DNA polymerase on the mRNA expression level of Sema3A (accession no. NM_017310.1) standardized with the expression of hypoxanthine guanine phosphoribosyl transferase [HPRT, accession no. NM_012583.2 for rat cDNA cloning and sequence analysis originally determined by Chiaverotti et al. (17) ]. The intron-spanning primer sets used are as follows: for rat Sema3A, forward 5Ј-CTAT-CAGTGGGTGCCTTACCA-3Ј, reverse 5Ј-AGTCAGTGGGTCTC-CATTCCT-3Ј, annealing temperature 61°C, 30 -32 cycles, amplicon 607 nucleotides (nt); for murine HPRT, forward 5Ј-GCTGGT-GAAAAGGACCTCT-3Ј, reverse 5Ј-CACAGGACTAGAACRYCTGC-3Ј, annealing temperature 62°C, 25-27 cycles, amplicon 249 nt. The annealing temperatures and cycle numbers were optimized so that the amplification reactions are within the linear range. The PCR products were visualized with ethidium bromide after 1.5% agarose gel electrophoresis.
mRNA expressions of Sema3A and myogenin (accession no. NM_017115.2) were also monitored by real-time quantitative PCR using Roche LightCycler1.5 run under the TaqMan probe detection format standardized with HPRT expression. The primer sets were designed by the ProbeFinder (version 2.35 for rat, Roche) with an intron-spanning assay: for rat Sema3A, forward 5Ј-TTTCAGCAAT-GGAGCTTTCTACT-3Ј, reverse 5Ј-CGGTGTAGAGGAAGCTGT-GC-3Ј, amplicon 82 nt; for rat myogenin, forward 5Ј-CCTTGCT-CAGCTCCCTCA-3Ј, reverse 5Ј-TGGGAGTTGCATTCACTGG-3Ј, amplicon 94 nt; for murine HPRT, forward 5Ј-GACCGGTTCTGT-CATGTCG-3Ј, reverse 5Ј-ACCTGGTTCATCATCACTAATCAC-3Ј, amplicon 61 nt. Annealing temperature was set to 60°C in all cases.
BrdU incorporation assay. Cultures were pulse labeled with 10 M BrdU in DMEM-10% HS for the final 2 h at each time point from 24 to 96-h postplating, followed by immunocytochemistry for detection of BrdU using a G3G4 anti-BrdU monoclonal antibody [1:100 dilution in 0.1% BSA in phosphate-buffered saline (PBS)] and a HRPOconjugated anti-mouse IgG antibody (1:500 dilution) according to Tatsumi et al. (65) . The percentage of BrdU-labeled cells is an indicator of activation (entry into the cell cycle) and the subsequent proliferation activities of satellite cells, being useful for monitoring cell stage progression during cell culturing along with the myogenin mRNA expression assay by the real-time RT-PCR described above.
ECL-Western blotting and immunocytochemistry of Sema3A. Whole cell lysates and conditioned media (serum-free DMEM) from 72-h satellite cell cultures with and without HGF were applied to 10% polyacrylamide gel electrophoresis under reducing conditions (35) and transferred to nitrocellulose membranes using an electrode buffer of 25 mM Tris, 0.192 M glycine, 0.1% SDS, and 20% ethanol. The blots were blocked with 10% powdered milk in 0.1% polyethylene sorbitan monolaurate (Tween 20)-Tris buffered saline (TTBS) before incubation with polyclonal anti-Sema3A, anti-␣-tubulin, or anti-c-met antibodies (1:1,000 dilution in CanGetSignal solution 1 or 1% powdered milk-TTBS additionally containing 0.05% NaN3) overnight. Membranes were subsequently treated for 1 h with biotinylated secondary antibody at 1:5,000 dilution in CanGetSignal solution 2, then with HRPO-labeled avidin at a 1:500 dilution in TTBS for 30 min, followed by ECL detection onto Kodak BIOMAX X-ray films.
For immunolocalization of Sema3A in satellite cell cultures, 2.5 ng/ml HGF-cultures were fixed at 72-h postplating for 10 min in cold methanol-0.1% H 2O2 and blocked with 5% normal rabbit serum in 0.6% H 2O2-PBS for 30 min before incubation overnight in primary antibody to Sema3A and c-met (1:1,000 dilution in 5% normal rabbit serum-PBS). For desmin staining, fixed cells were treated with 0.1% polyethylene glycol mono-p-isooctylphenyl ether (Triton X-100) in PBS for 10 min, then blocked with 5% goat serum in PBS for 30 min before incubation overnight in primary antibody (1:100 dilution in 0.1% BSA-PBS). Cells were subsequently incubated with HRPOlabeled secondary antibody for 1 h, followed by colorimetric determination with DAB substrate. Cells were monitored using an Olympus microscope and documented on a Nikon CoolPix950 digital camera.
Muscle fiber culture and immunodetection of Sema3A. Single mouse muscle fibers were isolated in duplicate experiments by collagenase digestion from the flexor digitorum brevis muscles of 2-3 C57BL/6 mice (8 -10 wk of age), plated on Purecol (collagen)-coated 35-mm petri dishes, and incubated for 24 h or 48 h with or without HGF (25 ng/ml) in basal growth media containing controlled serum replacement, as previously described (78 -80) . Dishes cultured for 24 h also contained BrdU to label DNA synthesis in activated satellite cells. After culturing, dishes were rinsed and fixed in acid alcohol, air dried, and stored in TBS with 1% HS until immunostaining for BrdU incorporation (78) or Sema3A. Additional dishes were fixed and stained for Sema3A immediately after plating. Sema3A immunostaining was obtained using an IHCWorld protocol (29) that employed multiple blocking steps, including normal goat serum, the Fab fragment of goat anti-rabbit IgG, and avidin and biotin, all before primary-antibody detection with rabbit anti-Sema3A (1:350 dilution). This was followed by incubation with secondary antibody, the Fab fragment of biotinylated goat anti-rabbit (1:500 dilution), and color detection with HRPO-conjugated streptavidin (1:500) and DAB with color intensifier. Dishes were coverslipped with Immunomount and left to dry before viewing and photography on the Zeiss ApoTome used oil immersion lenses for differential interference contrast (DIC) and epifluorescence imaging to view Sema3A staining in muscle sections.
To confirm HGF had induced satellite cell activation in fiber cultures, the number of BrdU-positive satellite cells per fiber was counted at ϫ400 for all fibers in each dish. The mean and standard error of at least three dishes per treatment (each with 15 to Ͼ100 fibers) are reported, and the distribution of staining frequency was compared between control and HGF-treated dishes using 2 -statistics. Sema3A staining was viewed and photographed at ϫ1,000 under oil immersion. As a control for Sema3A staining, frozen sections of normal mouse gastrocnemius muscle were also stained for Sema3A. Negative-control sections and negative-control dishes of fibers (from the same experiments as those stained for Sema3A) were processed at the same time, with the omission of primary antibody, and there was no staining of satellite cells or fibers in either anti-BrdU or antiSema3A negative-control preparations.
In vivo muscle crush and Sema3A expression analyses. Ninemonth-old male Sprague-Dawley rats were anesthetized with an intraperitoneal injection of sodium 5-ethyl-5-(1-methylbutyl)barbiturate (pentobarbital sodium; 0.05 mg/g body wt), and one lower hindlimb of each rat was crushed twice by closing a pair of hemostat forceps with grooved jaws over the skin and posterior-compartment muscles for 5 s (see Fig. 6A ). Every 2 days postcrush, satellite cells were prepared from the lower hindlimb muscle group according to the procedure described previously (3), which was modified to include additional filtration of cells through nylon cell strainers (100 and 40 m of mesh size) to ensure separation from tissue debris before the final centrifugation step at 1,500 g for 3 min. Cells were then directly evaluated for the expression of Sema3A and myogenin mRNAs (without plating) by real-time RT-PCR standardized with HPRT. Additionally, companion satellite cell preparations were plated and maintained in DMEM-10% HS for 24 h, followed by immunocytochemistry for expression of Sema3A and desmin proteins; briefly, cells were fixed for 10 min in cold methanol-H 2O2-PBS and blocked with Image-iT FX for 40 min before incubation in primary antibody to desmin (1:100 dilution in 3% BSA-PBS, for 8 h at room temperature) and the Alexa Fluor 594-labeled secondary antibody (1:1,000 dilution in 3% BSA-PBS, for 1 h at room temperature). Subsequently, cells were incubated in anti-Sema3A antibody (1:1,000 dilution, overnight at 4°C) and the Alexa Fluor 488-conjugated secondary antibody (1:1,000 dilution, for 1 h at room temperature), followed by mounting in Prolong Gold with DAPI. Fluorescence was monitored using a Nikon Diaphot TMD300 fluorescence microscope and documented on a Nikon D40X digital camera.
Animal care and use. All experiments involving animals were conducted according to institutional guidelines and with the approval of Kyushu University Institutional Review Board, the University of Arizona, and the University of Manitoba Institutional Animal Care and Use Committees.
Statistical analysis. Analysis of variance procedures were employed to analyze experimental results using general linear model procedures of SRISTAT2 for Windows software (Social Survey Research Information, Tokyo, Japan). Least-squares means for each treatment were separated on the basis of least significant differences. Data are represented as means Ϯ SE for three cultures or rats per treatment. Data were considered significantly different from the mean in control cultures when P Ͻ 0.05. Each in vitro experiment was repeated two or three times to verify the reproducibility of results, and, in most cases, one rat was used for each group per experiment.
RESULTS

HGF upregulates Sema3A expression in satellite cells at differentiation phase in vitro.
The purpose of this study was to examine whether satellite cells can produce Sema3A in response to certain growth factor(s) found in adult skeletal muscles. HGF was considered the first candidate for investigation because, of all growth factors studied thus far, only HGF is established as an essential cue for activating myogenesis during postnatal muscle growth and regeneration processes that include successful neuritogenesis and angiogenesis (2, 65, 69; reviewed in Ref. 70 ). Satellite cells were prepared from adult rat skeletal muscles and cultured for 72 h in DMEM-10% HS with or without 2.5 ng/ml recombinant HGF. This concentration of HGF stimulates the peak level of satellite cell activation in our culture system (67) and was therefore applied to the pilot experiments for Sema3A expression (Fig. 1) . Figure 1A demonstrates a typical RT-PCR analysis for Sema3A message in cultured satellite cells at each time point. The Sema3A transcript was faintly detected in control cultures throughout the period, and an increase in Sema3A expression was seen clearly in HGF-treated cultures at the 72-h time point, before any response in proliferation was observed (see below). Sema3A upregulation by 2.5 ng/ml HGF was also demonstrated by Western blotting of the 72-h cultured cell lysates, since there was an increase in the intensity of the single 97-kDa band (at the molecular weight of Sema3A) standardized relative to the level of ␣-tubulin protein in the same lane (Fig. 1B) . The percentages of cells positive for Sema3A and for myogenic cell markers c-met and desmin, in the 72-h HGF-treated cultures, were 95.3 Ϯ 1.55, 96.5 Ϯ 0.30, and 96.1 Ϯ 0.53% (means Ϯ SE), respectively, as revealed by immunocytochemistry (Fig.  1C) . Together, these data provide evidence that HGF-treated satellite cells isolated from adult rat muscle produce Sema3A at 72-h postplating.
This issue was further examined by assessing the time course of Sema3A upregulation by HGF addition to the culture media. In experiments displayed in Fig. 2 , A and B, satellite cells were cultured with 2.5 ng/ml HGF for 24 h, where the start-end times for treatment varied (0 -24, 24 -48, and 48 -72 h, referred to hereinafter by superscripts), and all cultures were assayed for Sema3A mRNA expression at 72-h postplating using semiquantitative RT-PCR and real-time quantitative RT-RCR. Sema3A upregulation was induced exclusively in the HGF 48-72 h cultures, and the expression was increased to a level equivalent to that in positive-control cultures that received 2.5 ng/ml HGF throughout the culture period (HGF 0 -72 h , righthand lane and bar). By comparison, the cultures treated earlier with HGF, HGF 0 -24 h and HGF 24 -48 h cultures, showed no significant response relative to the control cultures without exposure to HGF. These results demonstrate that Sema3A upregulation results from exposure to HGF (2.5 ng/ml) between 48 and 72 h postplating, the time that corresponds to the early-differentiation period characterized by increasing levels of myogenin expression and the concurrent decrease in BrdUincorporation activity of differentiating satellite cells (Fig. 2C) .
Subsequent experiments were conducted to survey other growth factors for potential to upregulate Sema3A expression; results are shown in lacking a binding ability for IGF-I-binding proteins), PDGF-BB, transferrin, TGF-␤2, and EGF, some of which were found in crushed muscle extract (11, 15, 16, 65) and are known to be involved in postnatal myogenesis. Satellite cell cultures were treated with each growth factor at two concentrations (2.5 and 25 ng/ml) for the 24-h period starting from 48-h postplating and assayed at 72-h postplating by quantitative RT-PCR. Cultures receiving HGF again showed increased Sema3A expression and served as positive controls in the experiment (solid bars). All the other growth factors examined had no significant effect on Sema3A expression at either concentration, with the exceptions of a small inductive effect of EGF and an inhibitory effect of TGF-␤2 (Fig. 3A, open bars) . Similar results were also observed in cultures treated with each growth factor throughout the culture period (0 -72 h) (data not shown). These observations highlight a prominent role for HGF among various growth factors in skeletal muscle, as a potent cue to upregulate Sema3A expression in adult satellite cells in culture. The physiological significance of this finding is supported by the experiment to study the HGF-dose dependence of Sema3A expression shown in Fig. 3B . In the same experimental conditions as for Fig. 3A , Sema3A message was demonstrated to be upregulated with increasing concentrations of HGF and reached to a plateau (a value about 7-to 8-fold higher than control) at 10 -25 ng/ml, a dose that is considered within the physiological HGF concentration range seen in regenerating skeletal muscles. At the protein level, Western blotting experiments showed that whole cell lysates of the cultures treated with 25 ng/ml HGF contained higher levels of the 97-kDa band of Sema3A (relative to intracellular ␣-tubulin) compared with control cultures. In conditioned medium from HGF-treated cultures, 80-kDa and 66-kDa bands of Sema3A were clearly detected along with a faint staining of 97-kDa band (inset in Fig. 3B ); these 80-kDa and 66-kDa products may be generated by differential proteolytic processing of 97-kDa pro-Sema3A, which was originally described by Adams et al.
(1) and demonstrated to regulate the chemorepulsive potency of secreted Sema3A through furin-or furin-like endoproteasedependent pathways during the embryonic development of the mouse (1, 45) . These findings indicate that satellite cells produce and secrete Sema3A protein into the culture medium in response to HGF, therefore supporting a paracrine function of satellite cell-derived Sema3A.
HGF treatment of single, isolated mouse fibers in culture induced an increase in satellite cell activation. Fibers were treated with or without 25 ng/ml HGF and were cultured for 24 h in the presence of BrdU to label DNA synthesis. The number of BrdU-positive satellite cells per fiber was significantly higher in cultures treated with HGF (control, 0.054 Ϯ 0.005; HGF-treated, 0.13 Ϯ 0.02) (P ϭ 0.02, Fig. 4A ). Sema3A staining was infrequent on control fibers, with ϳ10% of fibers displaying one, or occasionally two satellite cells in dishes cultured without HGF (Fig. 4B) . Fibers fixed immediately after plating showed the same distribution of Sema3A in a small number of satellite cells. Negative-control dishes showed no staining of satellite cells (neg). Background staining in fibers was very low or absent in all conditions. Staining for Sema3A was observed in the cytoplasm of satellite cells, often extending along a segment of the fiber length on either side of a satellite cell nucleus (C-i, C-ii). In one fiber that displayed a very prominent motor end-plate region of synaptic folds, the satellite cell at the end-plate stained intensely for Sema3A relative to other Sema3A-positive satellite cells in that dish of fibers (C-iii). This localization of Sema3A, in satellite-cell cytoplasm but not in fibers, was identical in sections of gastrocnemius muscle from normal mouse (Fig. 4C) . In fiber cultures that were exposed to HGF (25 ng/ml for 48 h), the intensity of satellite cell staining was greatly increased compared with control dishes cultured without HGF or fibers in dishes fixed immediately after plating (HGF-iv, HGF-v). Sema3A-positive satellite cells were often observed as rounded cells attached to fibers, likely resulting from HGF-induced activation. As well, the frequency of Sema3A-positive satellite cells was increased after culturing with HGF: over 50% of fibers in HGF-treated dishes displayed one to three cells stained for Sema3A, compared with fibers in control dishes.
HGF-specific receptor c-met may not mediate the Sema3A expression signaling.
Having demonstrated the intense upregulation of satellite cell Sema3A by HGF, the potential role of a HGF-specific receptor in the signaling pathway for that response was examined. C-met is the only known signaling receptor for HGF to date, and its message and protein have been found in satellite cells in vitro and in vivo (2, 18, 40, 65, 78) . Figure 5A illustrates Sema3A expression in experiments in which satellite cells were maintained for 1 h in the presence of increasing concentrations of anti-c-met neutralizing antibody (0.01-1 g/ml) beginning 47-h postplating, followed by coaddition of 25 ng/ml HGF for the next 24 h, and then analyzed for Sema3A expression by quantitative RT-PCR. Treatment with the neutralizing antibody for c-met showed there was no significant decrease in Sema3A expression level within the range of antibody concentration that was examined. Experiments included a control culture treated with 25 ng/ml HGF plus 1 g/ml of a nonneutralizing antibody (bar b); this control culture responded by upregulation of Sema3A equivalent to the positive control culture treated with 25 ng/ml HGF (bar a). As a control to ensure that the anti-c-met antibody neutralized the activity of c-met in satellite cells, neutralizing antibody was examined in a satellite cell proliferation assay in conjunction with HGF. This assay was designed according to our previous -test). B: results of Sema3A immunostaining using anti-Sema3A antibody and secondary detection using the HRPO/diaminobenzidine (DAB) method. Staining is shown on differential interference contrast (DIC) images of control (C) and HGF-treated (HGF) fibers after 48 h in culture, or the absence of staining in a negative-control fiber (neg). Satellite cells on control fibers show low (C-i) to moderate (C-ii) staining (arrows) of the cytoplasm. One satellite cell located at a motor end-plate region (C-iii) shows relatively intense staining compared with other satellite cells on fibers in control cultures. HGFtreated fibers show intensely stained cytoplasm in satellite cells, here displayed as extending along part of the length of a fiber (HGF-iv) or rounded up (HGF-v) and apparently lifting off the fiber, likely due to the mobility of activated satellite cells in the presence of HGF. C: two examples (top row) of Sema3A-positive cytoplasm in satellite cells in cross section (C-i) and longitudinal section (C-ii) in gastrocnemius muscle from a normal mouse, achieved using an anti-Sema3A primary antibody detected with a fluorochrome-conjugated secondary antibody. Arrows point to the unstained nuclei of the Sema3A-positive satellite cells in the corresponding DIC images from the same fields (bottom row). All micrographs were obtained with a ϫ100 oil immersion objective except the lower-magnification images in left column of C, which were obtained with ϫ40 oil immersion objective. studies in which the incorporation of BrdU into satellite cells has been shown to be stimulated by HGF in a dose-dependent manner with a maximum at 2.5-10 ng/ml (67) . Increasing concentrations of anti-c-met antibody gradually decreased and then abolished the HGF-induced activation of satellite cells, dropping BrdU incorporation to a level comparable to the control cultures (Fig. 5B and bar C) . Control antibody showed no inhibitory effect even at 1 g/ml (bar b). In addition, the presence of c-met protein was evidenced at 72-h postplating by immunocytochemistry of HGF-treated satellite cells (Fig. 1C) and was further confirmed by Western blot detection of bands corresponding to the pro-c-met form and the ␤-chains of the active form in the cell lysates at 48-h and 72-h postplating, the same time points at which the neutralizing activity was determined (see inset in Fig. 5A ). Together, these data provide strong evidence that the receptor c-met may not mediate the signaling pathway that links the ligand HGF and Sema3A expression.
Satellite cells upregulate Sema3A expression at differentiation stage in response to in vivo muscle crush injury.
The final experiments were conducted to examine the ability of satellite cells to express the Sema3A message and protein in response to muscle injury (Fig. 6) . In adult rats, the posterior compartment muscles of one lower hindlimb were crushed by a hemostat forceps to produce a muscle injury (Fig. 6A) ; satellite cells were isolated and prepared for culture at a range of time points from 0 to 30-days postcrush and directly evaluated for Sema3A and myogenin mRNA expression by the quantitative RT-PCR (Fig. 6C) . The progression of muscle damage and regeneration was confirmed by histological observations of gastrocnemius-muscle cryosections that revealed many mononucleated cells and centrally nucleated muscle fibers as well as remnant areas of disrupted mature muscle fibers (see typical images from muscles 6-days postcrush shown in Fig. 6B ). Sema3A mRNA expression (solid bars) was significantly upregulated 2 days after crush injury, and this was observed in parallel with an increase in myogenin expression (open circles) in the same cell preparations. The level of Sema3A expression reached a plateau at 8-days postinjury (about 16-fold higher relative to day 0 control preparations) and subsequently returned to the baseline level within 30 days after injury. During this time, myogenin expression also decreased to a level equivalent to that observed in day 0 control preparations. Therefore, use of the crush injury model demonstrated that in vivo Sema3A upregulation began early in myogenic cell differentiation (at 2-4 days postinjury), evidenced by rising myogenin expression, and is consistent with the observations from in vitro satellite cell cultures shown in Fig. 2 .
The in vivo results do not necessarily prove that the satellite cells are responsible for Sema3A expression in injured muscle tissues, since the percentage of cells cultured from these preparations of crush injured and regenerating muscle was (72 h) without primary antibodies and with secondary reagents. Note that cell lysates were also stained with anti-␣-tubulin antibody to monitor the cell density on dishes (not for standardization of c-met proteins). B: the neutralizing activity of anti-c-met antibody for blocking receptor-ligand interaction was ensured by confirming changes in activation and proliferation using a BrdU incorporation assay on 48-h satellite cell cultures that received 2.5 ng/ml HGF in addition to the neutralizing antibody for the last 24-h period (see typical micrographs shown in inset; P and N, proliferating BrdU-positive and nonproliferative BrdU-negative cells, respectively); bar C and micrograph C, control culture treated without HGF; bar a and micrograph a, culture treated with 2.5 ng/ml HGF; bar b, culture treated with 2.5 ng/ml HGF plus 1 g/ml control antibody (goat IgG). Data points and bars depict means Ϯ SE for each of three cultures per treatment. **Statistically significant difference from the mean of the positive control culture (bars a) at P Ͻ 0.01. typically in the range of 70 -95% myogenic (desmin-positive), which is lower than the typical myogenic proportion of cells isolated from intact, undamaged muscles (Ͼ95%). Therefore it was possible that other mononuclear cells such as macrophagelike and fibroblast-like cells could be contaminating the cell preparations, and potentially be sources of Sema3A production. To test this possibility, the cell preparations from crushedregenerating muscle were plated and maintained for 24 h in culture medium, then prepared for double immunostaining for Sema3A (green) and the myogenic-cell marker desmin (red) as shown in Fig. 6D . During this short period in culture, Sema3A expression by inactive satellite cells is very low and does not change without an activating stimulus, as shown in Fig. 1A and Fig. 2, A and B ; therefore this in vitro assay procedure enables precise observation of the state of in vivo Sema3A protein expression by myogenic satellite cells in the period following muscle injury. Figure 6D displays typical immunocytochemical images of cell preparations isolated from injured muscles at 4 days and 8 days postcrush, the times at which Sema3A mRNA expression was first significantly upregulated (4 days) and then reached a plateau (8 days) (Fig. 6C) . Results of immunostaining demonstrated that Ͼ70% of the cells were positive for both Sema3A and desmin at both time points (n ϭ 3). Desmin-negative macrophage-and fibroblast-like cells comprised 5-30% of the cell isolates following muscle injury at these time points, and these cells showed negative or only very faint Sema3A expression (see the cells indicated by arrowheads in Fig. 6D ). Macrophage-like cells often displayed weak fluorescence for Sema3A restricted to the cytoplasmic compartment possibly due to phagocytosing myogenic cells, and these cells were included in Sema3A-positive cell percentages in the present experiment. Together, these data indicate Fig. 6 . Satellite cells produce Sema3A upon muscle injury. A: location of muscle crush injury in the lower posterior compartment of the hindlimb. Three rats were anesthetized and received a crush injury via hemostat to induce muscle regeneration. B: effects of the injury were monitored at 0-day and 6-days postcrush in cryosections of gastrocnemius muscle stained with hematoxylin-eosin (HE). C: at prescribed times after crush, satellite cells were prepared from the lower hindlimb muscle group and analyzed for the mRNA expression of Sema3A (solid bars) and myogenin (E) by real-time qRT-PCR standardized with HPRT (TaqMan probe assay). Data points and bars depict means Ϯ SE for three rats per time point. *,**Significantly different from control at P Ͻ 0.05 and P Ͻ 0.01, respectively. D: satellite cell preparations from the same muscles at 4-days and 8-days postcrush were plated and maintained in DMEM-10% HS for 24 h and were then prepared by immunocytochemistry for expression of Sema3A (green) and desmin proteins (red) using respective primary antibodies and Alexa Fluor-labeled secondary antibodies. The percentage of epitope-positive cells in each preparation is shown under the micrographs as the mean Ϯ SE for cultures from the three rats. CNT, control cells without primary antibody and with both secondary antibodies (merged image). Macrophage-like and fibroblastlike cells are indicated by arrowheads and outlined with dotted lines as matched by the cells in the phase contrast images.
that myogenic mononuclear cells upregulate the Sema3A message and protein in response to crush injury at the time of myogenic cell differentiation during regeneration in vivo.
DISCUSSION
Satellite cell activity is critical for successful skeletal muscle repair and hypertrophy, processes that are commonly initiated by mechanical or chemical insults. One of the earliest events following insult is the activation of quiescent satellite cells triggered through HGF/nitric oxide radical-dependent pathways; activation enables satellite cells to migrate and enter the cell cycle and results in enhanced cell proliferation, differentiation, and fusion with muscle fibers. While satellite cells are essential in myogenesis during growth and regeneration, the satellite cell contributions to successful restoration of the vascular network and intramuscular motor innervation during muscle regeneration have not been examined to any great extent. A recent study by Rhoads et al. (53) used an in vitro model composed of cocultured satellite cells and microvascular fragments to demonstrate that satellite cells may mediate an angiogenic program through a functional pathway involving hypoxia-inducible factor and vascular endothelial growth factor (VEGF). Here we examined a parallel neuritogenically directed aspect of satellite cells that results suggest functions during muscle regeneration.
Regenerative mechanisms that regulate intramuscular motor innervation and the configuration of neuromuscular junctions are thought to reside in the spatiotemporal expression of axonguidance molecules and their receptors. Among several attractive and repulsive axon-guidance cues, Sema3A is characterized as a potent, secreted chemorepellent (13, 32, 42, 52, 63) . Sema3A transcripts were detected in terminal Schwann cells of a subset of neuromuscular synapses after gastrocnemius muscle denervation by sciatic-nerve crush or botulinum toxin A (BotoxA) injection (20) . These reports suggested that Sema3A may be important in directing intramuscular neuritogenesis during muscle regeneration and that terminal Schwann cells and also muscle satellite cells hold potential for Sema3A production that would ensure the detailed cross-talk where motor nerve terminals must be positioned at and near both Schwann cell and satellite cell populations.
Current experiments were designed to test the hypothesis that satellite cells can produce Sema3A in response to growth factors; our in vitro results clearly demonstrated the following points (Figs. 1-4 ): 1) Sema3A message and protein are upregulated when satellite cells are treated with recombinant HGF in primary cultures of cells and muscle fibers; 2) the other growth factors examined have no inductive effect with the exception of a small effect of EGF; 3) Sema3A upregulation by HGF shows a dose-dependent rise up to 7-to 8-fold vs. control; and 4) this event is initiated exclusively at the early-differentiation stage. While control cultures also progressed to the differentiation phase, a significant increase in Sema3A expression was not observed, indicating the importance of HGF as a cell stage-specific factor to initiate Sema3A synthesis. These results strongly reveal the heretofore unexplored role of satellite cells as a key source of Sema3A expression triggered by HGF in vitro. In vivo upregulation of Sema3A was also evident at the differentiation phase of satellite cells isolated from muscles regenerating from crush injury (Fig. 6) , supporting the in vitro findings. Notably, single myogenic-cell preparations from injured, regenerating muscle do not include differentiated satellite cells that have already fused with muscle fibers. Therefore the assays of Sema3A and myogenin expression in these cell preparations excluded protein expression by differentiated myogenic cells that had fused into fibers. This feature enabled the present experiment to evaluate specifically the injury-triggered response of only those myogenic cells that had proliferated and differentiated as single cells and remained external to muscle fibers. This subtle feature was required in the experimental design, since the probable localization of Sema3A production, and consequent paracrine contributions to intramuscular neuritogenesis by the secreted protein, would be expected to be external to muscle fibers during regeneration. Furthermore, the maximum expression of Sema3A mRNA in vivo (about 16-fold vs. uninjured controls) was higher than the maximum 7-to 8-fold value for HGF-treated cultures, suggesting that growth factors other than HGF and EGF likely also make important contributions to mediating Sema3A expression in vivo. Alternatively, the methodology for standardizing Sema3A-expression relative to HPRT in samples of regenerating muscle may have been affected by the HPRT contents of Sema3A-negative macrophage-and fibroblast-like cells (observed at about 5-30% abundance in the cell preparations), since their HPRT content could differ considerably from that in satellite cells. Such an effect could over-or underestimate Sema3A expression in vivo, so discussion of the significance of apparently differential Sema3A expression between activated satellite cell cultures and in vivo regeneration is premature.
The detailed mechanism by which HGF treatment results in Sema3A upregulation is yet to be determined. However, the HGF-specific receptor, c-met, may now be excluded from the pathway. The findings in Fig. 5 implicate an unknown HGF receptor in the mechanism of Sema3A upregulation by HGF. The nature of the alternate receptor system is unclear, but additional evidence for an alternative pathway is emerging from experiments in which high concentrations of HGF were shown to stimulate expression of myostatin through a pathway that does not involve c-met (71a). Considering that EGF showed a low inductive effect on Sema3A expression (ϳ30% relative to HGF), it is interesting to speculate on the original divergence in signaling between induction of Sema3A expression and activation. It is possible that the respective receptors for HGF and EGF might contribute to the functional separation of the two signals for Sema3A expression and activation, despite their similar HGF dependence. Alternatively, a functionally shared receptor common to both HGF and EGF may show differential binding (with different association constants) to the two ligands and could partially enable the differential signal for Sema3A upregulation and satellite cell activation. However, since HGF and EGF proteins do not have significant sequence homology, a receptor using protein-protein interactions for ligand binding seems unlikely. Therefore, a plausible candidate receptor might be the glycosaminoglycan chain shared by proteoglycans and proteoglycan-like transmembrane proteins (phosphacans), which is known to associate with variety of growth factors and mediate their intracellular signaling (38; reviewed in Refs. 14, 46, and 77). For example, an intracellular domain of syndecans, phosphacans, or their associated coreceptor proteins may be involved in HGF signaling that mediates Sema3A expression. Considering the implication of receptors other than c-met and downstream molecules that mediate HGF-induced Sema3A expression, these signaling proteins are hypothesized to be expressed exclusively by satellite cells early in myogenic differentiation; that expression pattern would account for the cell stage-specific requirement for HGF in initiating Sema3A upregulation.
It is worth noting that the control cell cultures expressed a faint level of Sema3A message and protein throughout the culture period. Similar results were observed on a cellular level as variable zero-to-moderate staining for Sema3A in satellite cells on fibers plated and fixed immediately or cultured without HGF treatment. This observation suggests that the control level of expression has a physiological significance in uninjured muscle. Baseline expression was not diminished by addition of anti-HGF neutralizing antibody or control antibody (goat IgG) to the culture media (Fig. 3A, bars a and b) , at the concentration optimized previously as providing maximal inhibition of activation by intrinsic HGF (66, 67) , and therefore useful in defining whether endogenous HGF activity generated from satellite cells themselves (58, 66, 67) is implicated in the faint Sema3A expression observed in the lysates of control cultures. Results indicated that the basal level of Sema3A expression may be independent of HGF; other regulatory axon-repellent mechanisms may therefore contribute to maintain or stabilize an established motoneuron network including neuromuscular connections, in coordination with the attractive axon-guidance molecules. The present findings suggest the possibility of that regulatory process may be mediated, in part, directly and actively by muscle satellite cells, and also that those processes may be nerve independent (as is early muscle regeneration).
Finally, an important issue for discussion may be a comparison with De Winter's experiments using gastrocnemius muscle denervation (20) . Sema3A message was selectively expressed in terminal Schwann cells at neuromuscular junctions of type IIb/x (fast-twitch) muscle fibers and not type I and IIa (slower-twitch) fibers; these findings were elegantly revealed by the combination of in situ hybridization and quantitative RT-PCR techniques. As well, the same experiments showed that upregulation of Sema3A expression in terminal Schwann cells was not observed in the denervated soleus muscle that is devoid of type IIb/x muscle fibers, supporting the finding of muscle fiber type-specific induction of Sema3A by denervation. While our experiments were designed to focus on satellite cell functions and did not permit observations of whether terminal Schwann cells were positive for Sema3A expression, the interesting and highly likely possibility that terminal Schwann cells also respond to muscle crush injury, as shown for muscle denervation, remains to be determined. In our satellite cell culture system, however, comparative study for Sema3A-expression activity of satellite cells from different muscles showed that soleus muscle [with Ͻ0.1% type IIb/x fibers, according to SDS-PAGE analysis of myosin heavy chain isoforms by Mizunoya et al. (41) ] had a significantly higher Sema3A response to HGF than cells from the fasttwitch extensor digitorum longus muscle (P Ͻ 0.01; T. Suzuki and R. Tatsumi, unpublished observations). These findings suggest that Sema3A physiology in muscle may differ from the Schwann cell phenomenon that followed muscle denervation (20) . Nonetheless, this report demonstrates that satellite cells can initiate synthesis and upregulate expression of the neural chemorepellent, Sema3A, early in cell differentiation in response to HGF in vitro and to muscle crush injury in vivo.
The physiological significance of this satellite cell response to HGF is supported by the positive HGF dose-dependent response of Sema3A expression, which peaked at 10 -25 ng/ ml, within the physiological range of HGF (Fig. 3B) . Extracellular HGF concentrations increase in response to muscle injury, mechanical stretch, exercise, and the nitric oxide radical, possibly due to the HGF release from the extracellular matrix of muscle fibers and satellite cells (30, 60 -62, 65, 68, 69, 81) and HGF synthesis by satellite cells (4, 58) . Actually, in our crush injury model, HGF message in whole gastrocnemius muscle increased about fivefold relative to control muscle at 0 and 6 days postcrush, as revealed by real-time RT-PCR analysis (data not shown). In addition, Suzuki et al. (61) demonstrated that spleen and liver cells respond to muscle injury to produce HGF message and protein, resulting in increased serum levels of HGF that may be delivered via blood flow to the extracellular space in regions of damage. Early in these situations, satellite cells can be rapidly activated to enter the cell proliferation cycle through a low level HGF/nitric oxide radical-dependent cascade as shown by Anderson's and Allen's groups (2, 3, 5, 6, 65-67, 69, 71, 78 -82, 84, 85 ; reviewed in Refs. 7, 8, and 70). Shortly after activation, proliferating satellite cells begin to differentiate and synthesize Sema3A; during the same phase early in differentiation, the extracellular HGF concentration may be increasing. Fiber culture experiments demonstrated this sequence at the cellular level, by showing HGF-induced activation of satellite cells on fibers after 24 h in culture, and a strong increase in the intensity of satellite cell staining for Sema3A 48 h after plating, when differentiation and myogenin expression are typically established in fiber cultures (83) . As a consequence, the Sema3A expression pathway, including synthesis of an alternative HGF receptor distinct from the c-met receptor that mediates satellite cell activation pathways (7, 81) and/or intracellular signaling molecules such as the myostatin inhibitor follistatin (51), may be exclusively turned on. The results therefore encourage the speculation that the expression and secretion of Sema3A from satellite and satellite-derived myogenic cells may mediate restoration or remodeling of the nerve muscle connections Fig. 7 . A1-A3: schematic representation of a model for HGF-dependent Sema3A upregulation and secretion in response to muscle injury. In undamaged muscle fibers, small populations of satellite cells are in proliferation and differentiation stages (Ͻ5-10% incidence, being likely responsible for the renewal of the cells or turnover of myonuclei in undamaged normal muscle fibers; see Ref. 12 ) and secrete basal level of Sema3A as a communication molecule that may function to maintain established neuromuscular connections and adjustment of intramuscular motoneuron network (A1). After muscle injury including the lesion of motoneuron branches and the integrity of the sarcolemma, satellite cells can be immediately activated to enter the cell proliferation cycle [see Fig. 4 in the review article by Tatsumi and Allen (70) for more detail] and then begin to differentiate (reviewed in Refs. 3, 7, 8, 12, and 70) ; at this time, the extracellular HGF concentration may be still increasing and hence the HGF-triggered Sema3A expression pathway may be turned on, causing growth-cone collapse and retraction and repelling motor axons during the regeneration period that restores muscle-fiber structure (A2). During the subsequent late-regeneration stage, the extracellular concentration of HGF decreases to a basal level, and TGF-␤2 might be upregulated, leading to downregulation of the Sema3A secretion. It is hypothesized that chemoattractive cues may be upregulated and secreted from restricted cell populations to guide motoneurons toward targets on regenerating muscle fibers (A3). The sequence of events during regenerative motoneuritogenesis described here may progress in coordination with recovery of muscle-fiber structure and contractile integrity (indicated by the black-to-white gradation in the bars on the right-hand side of A). B: model of the sequential processes of injury-triggered, HGF-mediated myogenesis and parallel processes of intramuscular neuritogenesis and angiogenesis that progress in a coordinated and time-dependent manner during adult skeletal muscle regeneration. When extracellular-HGF concentrations increase in response to mechanical stimuli, quiescent satellite cells are rapidly activated to enter the cell-proliferation cycle through a HGF-dependent cascade. Subsequently, many myogenic cells will enter differentiation (to enable their fusion into existing muscle fibers) while some cells in the population reenter mitotic quiescence (the G0 phase) in a manner dependent on high-level HGF-induced myostatin expression (71a) . Cells that progress into early differentiation express Sema3A to mediate restoration of neuromuscular connections and also possibly regulate vascular morphogenesis and endothelial cell migration. Presumed changes in the concentration of extracellular HGF are indicated by the black-to-white gradations in the bar. [Background graphics reproduced from scanning electron micrograph of Desaki and Uehara (19) through chemorepulsive events, including coordination of a delay in sprouting and reattachment of motoneuron terminals onto damaged muscle fibers in synchrony with recovery of muscle fiber structures that enable persistent or restored contractile activity, as modeled in Fig. 7, A1-A3 . In addition, Sema3A expression may potentially also regulate vascular morphogenesis through Sema3A-VEGF competitive binding to receptor neuropilins, and integrin-mediated endothelial cell adhesion and migration (57; reviewed in Ref. 22) .
Together, the previous reports and the present results lead to the idea that successful muscle regeneration, composed of myogenesis and intramuscular neuritogenesis and angiogenesis, may be a programmed sequence of events that respond to a mechanical insult or other perturbation in a synchronous, time-dependent, and coordinated manner (Fig. 7B) . Since TGF-␤2 decreases Sema3A expression to a level below controls (Fig. 3A) and the positive effect of 25 ng/ml HGF is completely prevented by coaddition of 2.5 ng/ml TGF-␤2 to the culture medium (N. Shimizu and R. Tatsumi, unpublished observations), the spatiotemporal regulation of HGF/EGF-induced Sema3A expression in vivo appears complex. This pathway has implications for understanding the coordination of muscle regeneration with neurito-and angiogenesis and the potential to combat loss of motor nerve innervation during aging.
